New Drug Being Tested to Fight Tropical Chagas Disease
CARACAS, Venezula-Researchers at the Venezuela Institute for Scientific Research have recently reported in the journal Science, they have made significant strides in developing a drug to treat tropical Chagas disease.
The South American form of Trypanosomiasis, Trypansoma cruzi, reportedly kills 50,000 people annually. The parasitic infection is spread through cockroach-sized insects that live in the walls and roofs of buildings. When they defecate, the waste lands on sleeping people below. The parasite enters through the skin. Children can also be infected at birth and via nursing. People can also receive contaminate blood containing the parasite.
While the scope of the bug's reach has been significantly limited after South American government sponsored insecticide spraying of building and new blood testing methods. However, the infections persist.
Researchers working with a variety of drugs have tried to find a method of killing the parasite before it is able to burrow into the heart and intestine. They have been close in finding an effective treatment in antifungal drugs, but have produce incredible results with an anticholesterol drug manufactured by AstraZeneca.
The drug blocks ergosterol synthesis in trypansomes, which significantly reduces the number of amastigote parasites that infect the human heart and intestinal tissue.
The specific drug wasn't mentioned in the literature, however the compound responsible for both aiding in cholesterol and reducing the parasitic count is called BPQ.
Information from the journal Science
Beyond the Surface: Rethinking Environmental Hygiene Validation at Exchange25
June 30th 2025Environmental hygiene is about more than just shiny surfaces. At Exchange25, infection prevention experts urged the field to look deeper, rethink blame, and validate cleaning efforts across the entire care environment, not just EVS tasks.
A Controversial Reboot: New Vaccine Panel Faces Scrutiny, Support, and Sharp Divides
June 26th 2025As the newly appointed Advisory Committee on Immunization Practices (ACIP) met for the first time under sweeping changes by HHS Secretary Robert F. Kennedy Jr, the national spotlight turned to the panel’s legitimacy, vaccine guidance, and whether science or ideology would steer public health policy in a polarized era.
Getting Down and Dirty With PPE: Presentations at HSPA by Jill Holdsworth and Katie Belski
June 26th 2025In the heart of the hospital, decontamination technicians tackle one of health care’s dirtiest—and most vital—jobs. At HSPA 2025, 6 packed workshops led by experts Jill Holdsworth and Katie Belski spotlighted the crucial, often-overlooked art of PPE removal. The message was clear: proper doffing saves lives, starting with your own.
